| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.049 | 0.4 |